Search Results

Researchers Submit Patent Application, "Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor X", for Approval (USPTO 202.

Subjects: BLOOD coagulation factor IX; BISPECIFIC antibodies; BLOOD coagulation factors

• Source: Immunotherapy Weekly; 2024, p934-934, 1p

Record details

"Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor X" in Patent Application Approval Process (USPTO 20230159658).

Subjects: BLOOD coagulation factor IX; BISPECIFIC antibodies; BLOOD coagulation factors

• Source: Immunotherapy Weekly; 6/13/2023, p635-635, 1p

Record details

Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era.

• Authors : GIROLAMI, A.; VETTORE, S.; SCARPARO, P.

Subjects: HEMOPHILIA; BLOOD diseases; BLOOD coagulation factor XIII

• Source: Haemophilia. Jan2011, Vol. 17 Issue 1, p17-20. 4p.

Record details

Patent Issued for Bispecific antibodies for factor IX and factor X (USPTO 11919969).

• Source: Gene Therapy Weekly; 2024, p725-725, 1p

Record details

A family with hereditary factor X deficiency with a point mutation Gla[sup 32] to Gln in the Gla domain (factor X Tokyo).

• Authors : Zama, Takeru; Murata, Mitsuru; Watanabe, Reiko

Subjects: *BLOOD coagulation factors; *GENETICS; *GENETIC mutation

• Source: British Journal of Haematology. Sep99, Vol. 106 Issue 3, p809-811. 3p. 1 Diagram.

Record details

Researchers Submit Patent Application, "COAGULATION FACTOR X (F10) iRNA COMPOSITIONS AND METHODS OF USE THEREOF", for Approval (USPTO 20240117348).

Subjects: BLOOD coagulation factors; PATENT applications; RESEARCH personnel

• Source: Hematology Week; 5/3/2024, p820-820, 1p

Record details

Researcher from Nanjing Medical University Describes Findings in Colon Cancer (Genetic Susceptibility of Thrombin Measurement Levels and the Risk of Colon Adenocarcinoma: A Mendelian Randomization Study).

Subjects: COLON cancer; THROMBIN; BLOOD coagulation factors

• Source: Hematology Week; 9/9/2024, p603-603, 1p

Record details

Factor X Deficiency.

• Authors : Marzia Menegatti

Subjects: BLOOD coagulation disorders; BLOOD coagulation factors; RARE diseases

• Source: Seminars in Thrombosis & Hemostasis; Jun2009, Vol. 35 Issue 4, p407-415, 9p

Record details

Molecular analysis of the genotype-phenotype relationship in factor X deficiency.

• Authors : Millar, David S.; Elliston, Lyn; Deex, Pippa

Subjects: MOLECULES; PHENOTYPES; GENOTYPE-environment interaction

• Source: Human Genetics; Feb2000, Vol. 106 Issue 2, p249-257, 9p

Record details

Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

• Authors : Wood, Jeremy P.¹; Bunce, Matthew W.²; Maroney, Susan A.¹

Subjects: *THROMBOPLASTIN; *BLOOD coagulation factor X; *BLOOD coagulation disorders

• Source: Proceedings of the National Academy of Sciences of the United States of America. 10/29/2013, Vol. 110 Issue 44, p17838-17843. 6p.

Record details